The 'never-ending story' of the influence of blood specimen collection methods affecting the concentration, the zymographic profile and the usefulness of matrix metalloproteinases and their tissue inhibitors in multiple sclerosis diagnosis/prognosis: a landmark for limiting the misuse of serum samples

Comment

F Mannello et al. Mult Scler. 2007 Jun.

. 2007 Jun;13(5):687-90.

doi: 10.1177/1352458506072492. Epub 2007 Feb 9.

No abstract available

Comment in

Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies.
Fainardi E, Castellazzi M, Bellini T, Dallocchio F. Fainardi E, et al. Mult Scler. 2007 May;13(4):561-2. doi: 10.1177/1352458506070897. Epub 2007 Feb 9. Mult Scler. 2007. PMID: 17463079 No abstract available.
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies.
Fainardi E, Castellazzi M, Bellini T, Dallocchio F. Fainardi E, et al. Mult Scler. 2007 Jun;13(5):691-2. doi: 10.1177/1352458507080433. Mult Scler. 2007. PMID: 17615626 No abstract available.

Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.
Fainardi E, Castellazzi M, Bellini T, Manfrinato MC, Baldi E, Casetta I, Paolino E, Granieri E, Dallocchio F. Fainardi E, et al. Mult Scler. 2006 Jun;12(3):294-301. doi: 10.1191/135248506ms1274oa. Mult Scler. 2006. PMID: 16764342